TY - JOUR
T1 - Pre-operative coagulopathy management of a neonate with complex congenital heart disease
T2 - A case study
AU - Stammers, Alfred H.
AU - Rauch, Eric D.
AU - Willett, Lynne D.
AU - Newberry, Jamie W.
AU - Duncan, Kim F.
PY - 2000
Y1 - 2000
N2 - Severe coagulation defects often develop in neonates undergoing cardiac surgery, both as a result of the surgical intervention, and as pre-existing defects in the hemostatic mechanisms. The following case report describes a newborn patient with complex congenital heart disease and respiratory failure whose pre-operative coagulopathy was aggressively managed prior to surgical correction. A 5-day-old, 2.5 kg child presented with interrupted aortic arch, ventricular septal defect, atrial septal defect, and patent ductus arteriosus. On admission, he was in respiratory arrest suffering from profound acidemia. In addition, the child was hypothermic (30.1°C), septic (Streptococcus viridans). and coagulopathic (disseminated intravascular coagulation - DIC). The patient was immediately intubated and initial coagulation assessment revealed the following: prothrombin time (PT) 48.9 s (international normalized ratio (INR) 15.7). activated partial thromboplastin time (aPTT) > 106 s, platelet count 30,000 mm3, fibrinogen 15 mg dL-1 and antithrombin. Before cardiac surgery could be performed, the patient's DIC was corrected with the administration of cryoprecipitate(15 ml). fresh frozen plasma (300 mi), and platelets (195 ml). In spite of the large transfusion of fresh frozen plasma, the AT-III activity, measured as a percentage, remained depressed at 33. Initial thromboelastographic (TEG) determination revealed an index of +2.02, and following 100 IU administration of an AT-III concentrate, declined to -2.32. Sequential TEG profiles were performed over several days, with the results used to guide both transfusion and medical therapy. The congenital heart defect correction was subsequently performed with satisfactory initial results, but the patient developed a fungal infection and expired on the 16th post-operative day. The present case describes techniques of coagulation management for a newborn with both a severe hemostatic defect and congenital heart disease.
AB - Severe coagulation defects often develop in neonates undergoing cardiac surgery, both as a result of the surgical intervention, and as pre-existing defects in the hemostatic mechanisms. The following case report describes a newborn patient with complex congenital heart disease and respiratory failure whose pre-operative coagulopathy was aggressively managed prior to surgical correction. A 5-day-old, 2.5 kg child presented with interrupted aortic arch, ventricular septal defect, atrial septal defect, and patent ductus arteriosus. On admission, he was in respiratory arrest suffering from profound acidemia. In addition, the child was hypothermic (30.1°C), septic (Streptococcus viridans). and coagulopathic (disseminated intravascular coagulation - DIC). The patient was immediately intubated and initial coagulation assessment revealed the following: prothrombin time (PT) 48.9 s (international normalized ratio (INR) 15.7). activated partial thromboplastin time (aPTT) > 106 s, platelet count 30,000 mm3, fibrinogen 15 mg dL-1 and antithrombin. Before cardiac surgery could be performed, the patient's DIC was corrected with the administration of cryoprecipitate(15 ml). fresh frozen plasma (300 mi), and platelets (195 ml). In spite of the large transfusion of fresh frozen plasma, the AT-III activity, measured as a percentage, remained depressed at 33. Initial thromboelastographic (TEG) determination revealed an index of +2.02, and following 100 IU administration of an AT-III concentrate, declined to -2.32. Sequential TEG profiles were performed over several days, with the results used to guide both transfusion and medical therapy. The congenital heart defect correction was subsequently performed with satisfactory initial results, but the patient developed a fungal infection and expired on the 16th post-operative day. The present case describes techniques of coagulation management for a newborn with both a severe hemostatic defect and congenital heart disease.
UR - http://www.scopus.com/inward/record.url?scp=0034109368&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034109368&partnerID=8YFLogxK
U2 - 10.1177/026765910001500212
DO - 10.1177/026765910001500212
M3 - Article
C2 - 10789572
AN - SCOPUS:0034109368
VL - 15
SP - 161
EP - 168
JO - Perfusion (United Kingdom)
JF - Perfusion (United Kingdom)
SN - 0267-6591
IS - 2
ER -